The binding of PD‐1 to PD‐L1 can be prevented using ICBs such as anti‐PD‐1/PD‐L1 antibodies, which rejuvenate depleted T cells and thus inhibits tumor growth. The gene discussed is CD274; the disease is neoplasm.